Neu5Gc-associated Serum Immunoglobulin G Glycosylation as a Diagnostic Biomarker for Hepatocellular Carcinoma

Read full text Summarise with VIRAT
Authors: Xu Cao, Xiwei Lu, Qingwei Li, Jiali Lu, Xiaoping Song, Yinglun Han, Chunwen Pu, Yue Pang
Cited by: 0
References: 84

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background and Aims: Given the lack of efficient biomarkers for hepatocellular carcinoma (HCC) diagnosis, this study aimed to develop an HCC diagnostic strategy based on serum protein glycosylation signatures. We characterized differential N-glycosylation patterns of serum IgG to differentiate HCC from healthy controls and liver cirrhosis, and elucidated the molecular mechanisms driving aberrant Neu5Gc elevation in HCC to provide a theoretical basis for clinical application and differential diagnosis of HCC. Methods: and related gene clusters modulating Neu5Gc synthesis was conducted. Results: -knockout mouse experiments verified that an exogenous high-sialic-acid diet compensates for endogenous Neu5Gc synthesis deficiency, revealing a dietary-mediated compensatory mechanism for Neu5Gc elevation. Conclusions: This study established an LIP-ELISA-based clinical diagnostic platform combining AFP and Neu5Gc, defined sialic acid-modified glycan structures, and preliminarily identified regulators of Neu5Gc biosynthesis, providing novel insights for HCC diagnosis and mechanism research.

Fields of Study & Subjects

Glycosylation and Glycoproteins Research Hepatocellular Carcinoma Treatment and Prognosis Carbohydrate Chemistry and Synthesis

Publication details

Journal / source
Journal of Clinical and Translational Hepatology
Volume
000
Issue
000
Pages
000–000
Publication date
20 March 2026
Language
EN